Ocugen Inc
USPTO Trademark & Patent Filings
Trademark applications and grants for Ocugen Inc. Ocugen Inc has 9 trademark applications. The latest application filed is for "OCUGEN"
| Patent Application | Date |
|---|---|
| ADENO-ASSOCIATED VIRUS VECTOR MEDIATED GENE THERAPY FOR OPHTHALMIC DISEASES 20210123077 - 17/080078 Arumugham; Rasappa ; et al. | 2021-04-29 |
| OPHTHALMIC COMPOSITIONS AND METHODS OF USE 20190008920 - 16/116872 Arumugham; Rasappa ; et al. | 2019-01-10 |
| OPHTHALMIC COMPOSITIONS AND METHODS OF USE 20180333414 - 15/946709 Musunuri; Shankar ; et al. | 2018-11-22 |
| NANOEMULSIONS WITH ANTI-INFLAMMATORY ACTIVITY 20180333357 - 15/963955 Arumugham; Rasappa ; et al. | 2018-11-22 |
| PRSUSTAINED RELEASE OPTHALMIC FORMUATION AND METHODS FOR USING THE SAME 20180221278 - 15/944332 Arumugham; Rasappa ; et al. | 2018-08-09 |
| NCAGE Code | 70WN5 | OCUGEN, INC. |
| NCAGE Code | 8JDU2 | OCUGEN, INC. |
| CAGE Code | 8JDU2 | OCUGEN, INC. |
| DUNS | 079212680 | Ocugen, Inc. |
| SEC | 0001696601 | Ocugen, Inc. of DELAWARE |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 